Tech Company Financing Transactions
Weave Bio Funding Round
U.S. Venture Partners, Character VC and Innovation Endeavors participated in a $20 million Series A funding round for Weave Bio. The round was announced on 10/17/2025.
Transaction Overview
Company Name
Announced On
10/17/2025
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to accelerate product development and expand its commercial team.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Undisclosed
New Haven, CT New Haven
USA
New Haven, CT New Haven
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
At Weave we are on a mission to provide a technically robust, AI-enabled platform to address major pain points inherent in the pharma and biotech industries. We are passionate about enhancing customer capabilities with solutions that save significant time, return capacity to teams, lower overall costs, and ultimately decrease the time it takes to get treatments to patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ari Caroline
Chief Operating Officer
Sean Campbell
Chief Technical Officer
Umut Eser
VP - Bus. Development
Lindsay Mateo
VP - Engineering
Levi Malott
VP - Product Management
Brandon Rice
Browse more venture capital transactions:
Prev: 10/17/2025: Quantum Systems venture capital transaction
Next: 10/17/2025: Counsel Health venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs